Uttarakhand: Production of codeine-containing cough syrup at Windlass Biotech stopped ...
Reported Standalone quarterly numbers for Windlas Biotech are: Net Sales at Rs 233.10 crore in December 2025 up 19.53% from Rs. 195.02 crore in December 2024. Quarterly Net Profit ...
Net profit of Windlas Biotech declined 3.72% to Rs 15.00 crore in the quarter ended December 2025 as against Rs 15.58 crore during the previo ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
WINDLAS BIOTECH LTD - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 - Rediff MoneyWiz, the personal finance service from Rediff.com equips the user with tools and ...
Stay updated with the latest stock market news and live updates. Get real-time insights on Sensex Today, Nifty Live, stock market today, IPO news and more on Business Standard.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results